Jay D. Amsterdam / Mady Hornig / Andrew A. Nierenberg (eds.)
Treatment-Resistant Mood Disorders
Herausgeber: Amsterdam, Jay D.; Nierenberg, Andrew A.; Hornig, Mady
Jay D. Amsterdam / Mady Hornig / Andrew A. Nierenberg (eds.)
Treatment-Resistant Mood Disorders
Herausgeber: Amsterdam, Jay D.; Nierenberg, Andrew A.; Hornig, Mady
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
While antidepressants have helped millions worldwide, a substantial proportion of patients fail to respond or remit. There is little published information available to clinicians for diagnosis and management of treatment-resistant depression, so they have had to make difficult decisions about treatment options with very limited data. The editors and their internationally distinguished team of contributors have set out to address this problem, giving a critical assessment of all aspects of treatment-resistant depression: causes, epidemiology, comorbidity, evaluation and treatment. This timely…mehr
Andere Kunden interessierten sich auch für
Management of Treatment-Resistant Major Psychiatric Disorders162,99 €
Leslie CitromeHandbook of Treatment-resistant Schizophrenia38,99 €
Ather MuneerMood Disorders74,99 €
Mood Disorders122,99 €
Stavroula RakitziTreatment-Resistant Bipolar Disorder60,99 €
Stavroula RakitziTreatment-Resistant Schizophrenia56,99 €
Medication-Resistant Epilepsy109,99 €-
-
-
While antidepressants have helped millions worldwide, a substantial proportion of patients fail to respond or remit. There is little published information available to clinicians for diagnosis and management of treatment-resistant depression, so they have had to make difficult decisions about treatment options with very limited data. The editors and their internationally distinguished team of contributors have set out to address this problem, giving a critical assessment of all aspects of treatment-resistant depression: causes, epidemiology, comorbidity, evaluation and treatment. This timely book will be invaluable to clinicians, neuroscientists, researchers and graduate students.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 556
- Erscheinungstermin: 14. August 2007
- Englisch
- Abmessung: 244mm x 170mm x 30mm
- Gewicht: 947g
- ISBN-13: 9780521041812
- ISBN-10: 0521041813
- Artikelnr.: 23025937
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Cambridge University Press
- Seitenzahl: 556
- Erscheinungstermin: 14. August 2007
- Englisch
- Abmessung: 244mm x 170mm x 30mm
- Gewicht: 947g
- ISBN-13: 9780521041812
- ISBN-10: 0521041813
- Artikelnr.: 23025937
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
List of contributors; Preface; Part I. The Clinical Problem: 1. The
characterization and definition of treatment-resistant mood disorders
Daniel Souery, Olivier Lipp, Isabelle Massat and Julien Mendlewicz; 2.
Overview of treatment-resistant depression and its management John P.
O'Reardon and Jay D. Amsterdam; Part II. Biological Basis: 3.
Psychoneuroendocrine aspects of treatment-resistant mood disorders Owen M.
Wolkowitz and Victor I. Reus; 4. Estrogen and depressive illness in women
Barbara B. Sherwin; 5. Sleep abnormalities in treatment-resistant mood
disorders Martin P. Szuba, Antonio T. Fernando and Geralyn Groh-Szuba; 6.
Structural and functional brain imaging in treatment-resistant depression
Terence A. Ketter, Christopher J. Bench, Mark S. George, Tim A. Kimbrell
and Robert M. Post; 7. Immunologic factors in treatment-resistant
depression Anna Sluzewska, Janusz Rybakowski, Mady Hornig and Jay D.
Amsterdam; Part III. Treatment Approaches: 8. Selective serotonin reuptake
inhibitors and serotonin-norepinephrine reuptake inhibitors in
treatment-resistant depression William Boyer and Richard Bunt; 9.
Conventional and second generation monoamine oxidase inhibitors in
treatment-resistant depression David Bakish and Cynthia L. Hooper; 10. Drug
combination strategies Lawrence H. Price, Linda L. Carpenter and Steven A.
Rasmussen; 11. Electroconvulsive therapy in medication-resistant depression
Max Fink; 12. Thyroid augmentation Russell T. Joffe; 13. Cognitive therapy
and psychosocial interventions in chronic and treatment-resistant mood
disorders Jan Scott and Robert J. DeRubeis; Part IV. Special Patient
Populations: 14. Chronic and refractory mood disorders in childhood and
adolescence Adelita Segovia, Kelly N. Botteron and Barbara Geller; 15.
Treatment-resistant depression in the elderly Paul A. Newhouse and Jaskaran
Singh; 16. Management of treatment-resistant depression during pregnancy
and the postpartum period Zachary N. Stowe, Pamela McCreary, Amy Hostetter,
Claudia Baugh and Alexis Llewellyn; 17. Preliminary algorithms for
treatment-resistant bipolar depression Robert M. Post, Mark A. Frye, Kirk
D. Denicoff, Andrew M. Speer, Susan R. B. Weiss and Gabriele S. Leverich;
18. Medical disorders and treatment-resistant depression John P. O'Reardon
and Jay D. Amsterdam; 19. Psychiatric comorbidity in treatment-resistant
depression Jonathan E. Alpert and Isabelle T. Lagomasino; 20. Suicide in
treatment-refractory depression Jan Fawcett and Stanley G. Harris Sr; Part
V. Economic and Ethical Issues: 21. The economic impact of treatment
non-response in major depressive disorders Jeffrey S. McCombs, Glen L.
Stimmel, Rita L. Hui and T. Jeffrey White; 22. Ethical issues in research
and treatment of patients with mood disorders Paul Root Wolpe and Arthur
Caplan; Index.
characterization and definition of treatment-resistant mood disorders
Daniel Souery, Olivier Lipp, Isabelle Massat and Julien Mendlewicz; 2.
Overview of treatment-resistant depression and its management John P.
O'Reardon and Jay D. Amsterdam; Part II. Biological Basis: 3.
Psychoneuroendocrine aspects of treatment-resistant mood disorders Owen M.
Wolkowitz and Victor I. Reus; 4. Estrogen and depressive illness in women
Barbara B. Sherwin; 5. Sleep abnormalities in treatment-resistant mood
disorders Martin P. Szuba, Antonio T. Fernando and Geralyn Groh-Szuba; 6.
Structural and functional brain imaging in treatment-resistant depression
Terence A. Ketter, Christopher J. Bench, Mark S. George, Tim A. Kimbrell
and Robert M. Post; 7. Immunologic factors in treatment-resistant
depression Anna Sluzewska, Janusz Rybakowski, Mady Hornig and Jay D.
Amsterdam; Part III. Treatment Approaches: 8. Selective serotonin reuptake
inhibitors and serotonin-norepinephrine reuptake inhibitors in
treatment-resistant depression William Boyer and Richard Bunt; 9.
Conventional and second generation monoamine oxidase inhibitors in
treatment-resistant depression David Bakish and Cynthia L. Hooper; 10. Drug
combination strategies Lawrence H. Price, Linda L. Carpenter and Steven A.
Rasmussen; 11. Electroconvulsive therapy in medication-resistant depression
Max Fink; 12. Thyroid augmentation Russell T. Joffe; 13. Cognitive therapy
and psychosocial interventions in chronic and treatment-resistant mood
disorders Jan Scott and Robert J. DeRubeis; Part IV. Special Patient
Populations: 14. Chronic and refractory mood disorders in childhood and
adolescence Adelita Segovia, Kelly N. Botteron and Barbara Geller; 15.
Treatment-resistant depression in the elderly Paul A. Newhouse and Jaskaran
Singh; 16. Management of treatment-resistant depression during pregnancy
and the postpartum period Zachary N. Stowe, Pamela McCreary, Amy Hostetter,
Claudia Baugh and Alexis Llewellyn; 17. Preliminary algorithms for
treatment-resistant bipolar depression Robert M. Post, Mark A. Frye, Kirk
D. Denicoff, Andrew M. Speer, Susan R. B. Weiss and Gabriele S. Leverich;
18. Medical disorders and treatment-resistant depression John P. O'Reardon
and Jay D. Amsterdam; 19. Psychiatric comorbidity in treatment-resistant
depression Jonathan E. Alpert and Isabelle T. Lagomasino; 20. Suicide in
treatment-refractory depression Jan Fawcett and Stanley G. Harris Sr; Part
V. Economic and Ethical Issues: 21. The economic impact of treatment
non-response in major depressive disorders Jeffrey S. McCombs, Glen L.
Stimmel, Rita L. Hui and T. Jeffrey White; 22. Ethical issues in research
and treatment of patients with mood disorders Paul Root Wolpe and Arthur
Caplan; Index.
List of contributors; Preface; Part I. The Clinical Problem: 1. The
characterization and definition of treatment-resistant mood disorders
Daniel Souery, Olivier Lipp, Isabelle Massat and Julien Mendlewicz; 2.
Overview of treatment-resistant depression and its management John P.
O'Reardon and Jay D. Amsterdam; Part II. Biological Basis: 3.
Psychoneuroendocrine aspects of treatment-resistant mood disorders Owen M.
Wolkowitz and Victor I. Reus; 4. Estrogen and depressive illness in women
Barbara B. Sherwin; 5. Sleep abnormalities in treatment-resistant mood
disorders Martin P. Szuba, Antonio T. Fernando and Geralyn Groh-Szuba; 6.
Structural and functional brain imaging in treatment-resistant depression
Terence A. Ketter, Christopher J. Bench, Mark S. George, Tim A. Kimbrell
and Robert M. Post; 7. Immunologic factors in treatment-resistant
depression Anna Sluzewska, Janusz Rybakowski, Mady Hornig and Jay D.
Amsterdam; Part III. Treatment Approaches: 8. Selective serotonin reuptake
inhibitors and serotonin-norepinephrine reuptake inhibitors in
treatment-resistant depression William Boyer and Richard Bunt; 9.
Conventional and second generation monoamine oxidase inhibitors in
treatment-resistant depression David Bakish and Cynthia L. Hooper; 10. Drug
combination strategies Lawrence H. Price, Linda L. Carpenter and Steven A.
Rasmussen; 11. Electroconvulsive therapy in medication-resistant depression
Max Fink; 12. Thyroid augmentation Russell T. Joffe; 13. Cognitive therapy
and psychosocial interventions in chronic and treatment-resistant mood
disorders Jan Scott and Robert J. DeRubeis; Part IV. Special Patient
Populations: 14. Chronic and refractory mood disorders in childhood and
adolescence Adelita Segovia, Kelly N. Botteron and Barbara Geller; 15.
Treatment-resistant depression in the elderly Paul A. Newhouse and Jaskaran
Singh; 16. Management of treatment-resistant depression during pregnancy
and the postpartum period Zachary N. Stowe, Pamela McCreary, Amy Hostetter,
Claudia Baugh and Alexis Llewellyn; 17. Preliminary algorithms for
treatment-resistant bipolar depression Robert M. Post, Mark A. Frye, Kirk
D. Denicoff, Andrew M. Speer, Susan R. B. Weiss and Gabriele S. Leverich;
18. Medical disorders and treatment-resistant depression John P. O'Reardon
and Jay D. Amsterdam; 19. Psychiatric comorbidity in treatment-resistant
depression Jonathan E. Alpert and Isabelle T. Lagomasino; 20. Suicide in
treatment-refractory depression Jan Fawcett and Stanley G. Harris Sr; Part
V. Economic and Ethical Issues: 21. The economic impact of treatment
non-response in major depressive disorders Jeffrey S. McCombs, Glen L.
Stimmel, Rita L. Hui and T. Jeffrey White; 22. Ethical issues in research
and treatment of patients with mood disorders Paul Root Wolpe and Arthur
Caplan; Index.
characterization and definition of treatment-resistant mood disorders
Daniel Souery, Olivier Lipp, Isabelle Massat and Julien Mendlewicz; 2.
Overview of treatment-resistant depression and its management John P.
O'Reardon and Jay D. Amsterdam; Part II. Biological Basis: 3.
Psychoneuroendocrine aspects of treatment-resistant mood disorders Owen M.
Wolkowitz and Victor I. Reus; 4. Estrogen and depressive illness in women
Barbara B. Sherwin; 5. Sleep abnormalities in treatment-resistant mood
disorders Martin P. Szuba, Antonio T. Fernando and Geralyn Groh-Szuba; 6.
Structural and functional brain imaging in treatment-resistant depression
Terence A. Ketter, Christopher J. Bench, Mark S. George, Tim A. Kimbrell
and Robert M. Post; 7. Immunologic factors in treatment-resistant
depression Anna Sluzewska, Janusz Rybakowski, Mady Hornig and Jay D.
Amsterdam; Part III. Treatment Approaches: 8. Selective serotonin reuptake
inhibitors and serotonin-norepinephrine reuptake inhibitors in
treatment-resistant depression William Boyer and Richard Bunt; 9.
Conventional and second generation monoamine oxidase inhibitors in
treatment-resistant depression David Bakish and Cynthia L. Hooper; 10. Drug
combination strategies Lawrence H. Price, Linda L. Carpenter and Steven A.
Rasmussen; 11. Electroconvulsive therapy in medication-resistant depression
Max Fink; 12. Thyroid augmentation Russell T. Joffe; 13. Cognitive therapy
and psychosocial interventions in chronic and treatment-resistant mood
disorders Jan Scott and Robert J. DeRubeis; Part IV. Special Patient
Populations: 14. Chronic and refractory mood disorders in childhood and
adolescence Adelita Segovia, Kelly N. Botteron and Barbara Geller; 15.
Treatment-resistant depression in the elderly Paul A. Newhouse and Jaskaran
Singh; 16. Management of treatment-resistant depression during pregnancy
and the postpartum period Zachary N. Stowe, Pamela McCreary, Amy Hostetter,
Claudia Baugh and Alexis Llewellyn; 17. Preliminary algorithms for
treatment-resistant bipolar depression Robert M. Post, Mark A. Frye, Kirk
D. Denicoff, Andrew M. Speer, Susan R. B. Weiss and Gabriele S. Leverich;
18. Medical disorders and treatment-resistant depression John P. O'Reardon
and Jay D. Amsterdam; 19. Psychiatric comorbidity in treatment-resistant
depression Jonathan E. Alpert and Isabelle T. Lagomasino; 20. Suicide in
treatment-refractory depression Jan Fawcett and Stanley G. Harris Sr; Part
V. Economic and Ethical Issues: 21. The economic impact of treatment
non-response in major depressive disorders Jeffrey S. McCombs, Glen L.
Stimmel, Rita L. Hui and T. Jeffrey White; 22. Ethical issues in research
and treatment of patients with mood disorders Paul Root Wolpe and Arthur
Caplan; Index.







